MiMedx Comments on Magistrate Recommendation in the Company’s Lawsuit Against Short Sellers

January 18, 2018

Responsive image

MARIETTA, Ga., Jan. 18, 2018 /PRNewswire/ — MiMedx Group, Inc. (NASDAQ: MDXG), the leading biopharmaceutical company developing and marketing regenerative and therapeutic biologics utilizing human placental tissue allografts with patent-protected processes for multiple sectors of…

Category: Precious Metals